title: Is serum galectin-3 a potential predictor of the response to active specific immunotherapy in melanoma patients?
authors.forename: Pierre
authors.initials: P
authors.lastname: Vereecken
authors.forename: Michel
authors.initials: M
authors.lastname: Heenen
authors.forename: Sajida
authors.initials: S
authors.lastname: Babar
authors.forename: Nicolas
authors.initials: N
authors.lastname: Van Baren
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D037502:Galectin 3 / Q000097:blood*; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D008545:Melanoma / Q000097:blood* / Q000628:therapy*; D012878:Skin Neoplasms / Q000097:blood* / Q000628:therapy*; D018709:Statistics, Nonparametric
chemical_list: D014408:Biomarkers, Tumor; D037502:Galectin 3